<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39200834</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>16</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>09</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Demyelination in Patients with POST-COVID Depression.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">4692</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm13164692</ELocationID><Abstract><AbstractText><b>Background:</b> Depression is one of the most severe sequelae of COVID-19, with major depressive disorder often characterized by disruption in white matter (WM) connectivity stemming from changes in brain myelination. This study aimed to quantitatively assess brain myelination in clinically diagnosed post-COVID depression (PCD) using the recently proposed MRI method, macromolecular proton fraction (MPF) mapping. <b>Methods:</b> The study involved 63 recovered COVID-19 patients (52 mild, 11 moderate, and 2 severe) at 13.5 &#xb1; 10.0 months post-recovery, with matched controls without prior COVID-19 history (n = 19). A post-COVID depression group (PCD, n = 25) was identified based on psychiatric diagnosis, while a comparison group (noPCD, n = 38) included participants with neurological COVID-19 complications, excluding clinical depression. <b>Results:</b> Fast MPF mapping revealed extensive demyelination in PCD patients, particularly in juxtacortical WM (predominantly occipital lobe and medial surface), WM tracts (inferior fronto-occipital fasciculus (IFOF), posterior thalamic radiation, external capsule, sagittal stratum, tapetum), and grey matter (GM) structures (hippocampus, putamen, globus pallidus, and amygdala). The noPCD group also displayed notable demyelination, but with less magnitude and propagation. Multiple regression analysis highlighted IFOF demyelination as the primary predictor of Hamilton scores, PCD presence, and severity. The number of post-COVID symptoms was a significant predictor of PCD presence, while the number of acute symptoms was a significant predictor of PCD severity. <b>Conclusions:</b> This study, for the first time, reveals extensive demyelination in numerous WM and GM structures in PCD, outlining IFOF demyelination as a key biomarker.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khodanovich</LastName><ForeName>Marina</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-1856-0674</Identifier><AffiliationInfo><Affiliation>Laboratory of Neurobiology, Research Institute of Biology and Biophysics, Tomsk State University, 36 Lenina Ave., Tomsk 634050, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Svetlik</LastName><ForeName>Mikhail</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory of Neurobiology, Research Institute of Biology and Biophysics, Tomsk State University, 36 Lenina Ave., Tomsk 634050, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamaeva</LastName><ForeName>Daria</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-2760-0252</Identifier><AffiliationInfo><Affiliation>Laboratory of Neurobiology, Research Institute of Biology and Biophysics, Tomsk State University, 36 Lenina Ave., Tomsk 634050, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk 634014, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Usova</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory of Neurobiology, Research Institute of Biology and Biophysics, Tomsk State University, 36 Lenina Ave., Tomsk 634050, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cancer Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, 12/1 Savinykh Street, Tomsk 634028, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kudabaeva</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory of Neurobiology, Research Institute of Biology and Biophysics, Tomsk State University, 36 Lenina Ave., Tomsk 634050, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anan'ina</LastName><ForeName>Tatyana</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Laboratory of Neurobiology, Research Institute of Biology and Biophysics, Tomsk State University, 36 Lenina Ave., Tomsk 634050, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasserlauf</LastName><ForeName>Irina</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Laboratory of Neurobiology, Research Institute of Biology and Biophysics, Tomsk State University, 36 Lenina Ave., Tomsk 634050, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pashkevich</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Laboratory of Neurobiology, Research Institute of Biology and Biophysics, Tomsk State University, 36 Lenina Ave., Tomsk 634050, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moshkina</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory of Neurobiology, Research Institute of Biology and Biophysics, Tomsk State University, 36 Lenina Ave., Tomsk 634050, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Obukhovskaya</LastName><ForeName>Victoria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Laboratory of Neurobiology, Research Institute of Biology and Biophysics, Tomsk State University, 36 Lenina Ave., Tomsk 634050, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Fundamental Psychology and Behavioral Medicine, Siberian State Medical University, 2 Moskovskiy Trakt, Tomsk 634050, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kataeva</LastName><ForeName>Nadezhda</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Laboratory of Neurobiology, Research Institute of Biology and Biophysics, Tomsk State University, 36 Lenina Ave., Tomsk 634050, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology and Neurosurgery, Siberian State Medical University, 2 Moskovskiy Trakt, Tomsk 634028, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levina</LastName><ForeName>Anastasia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory of Neurobiology, Research Institute of Biology and Biophysics, Tomsk State University, 36 Lenina Ave., Tomsk 634050, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medica Diagnostic and Treatment Center, 86 Sovetskaya Street, Tomsk 634510, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tumentceva</LastName><ForeName>Yana</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Laboratory of Neurobiology, Research Institute of Biology and Biophysics, Tomsk State University, 36 Lenina Ave., Tomsk 634050, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasilieva</LastName><ForeName>Svetlana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk 634014, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schastnyy</LastName><ForeName>Evgeny</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk 634014, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naumova</LastName><ForeName>Anna</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4021-5343</Identifier><AffiliationInfo><Affiliation>Department of Radiology, School of Medicine, South Lake Union Campus, University of Washington, 850 Republican Street, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R24 NS104098</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>22-15-00481</GrantID><Agency>Russian Science Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">MPF</Keyword><Keyword MajorTopicYN="N">MRI</Keyword><Keyword MajorTopicYN="N">demyelination</Keyword><Keyword MajorTopicYN="N">depression</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">macromolecular proton fraction</Keyword><Keyword MajorTopicYN="N">magnetic resonance imaging</Keyword><Keyword MajorTopicYN="N">major depressive disorder</Keyword><Keyword MajorTopicYN="N">post-COVD</Keyword><Keyword MajorTopicYN="N">white matter</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>29</Day><Hour>1</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39200834</ArticleId><ArticleId IdType="pmc">PMC11355865</ArticleId><ArticleId IdType="doi">10.3390/jcm13164692</ArticleId><ArticleId IdType="pii">jcm13164692</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-Acute COVID-19 Syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T., Hittle M., Goodman S.N. Assessment of the Frequency and Variety of Persistent Symptoms among Patients with COVID-19: A Systematic Review. JAMA Netw. Open. 2021;4:e2111417. doi: 10.1001/jamanetworkopen.2021.11417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Pinto M.D., Borelli J.L., Mehrabadi M.A., Dutt N., Lambert N., Nurmi E.L., Chakraborty R., Amir M. COVID Symptoms, Symptom Clusters, and Predictors for Becoming a Long-Hauler: Looking for Clarity in the Haze of the Pandemic. Clin. Nurs. Res. 2022;31:1390&#x2013;1398. doi: 10.1177/10547738221125632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10547738221125632</ArticleId><ArticleId IdType="pmc">PMC9510954</ArticleId><ArticleId IdType="pubmed">36154716</ArticleId></ArticleIdList></Reference><Reference><Citation>de Erausquin G.A., Snyder H., Carrillo M., Hosseini A.A., Brugha T.S., Seshadri S. The Chronic Neuropsychiatric Sequelae of COVID-19: The Need for a Prospective Study of Viral Impact on Brain Functioning. Alzheimer&#x2019;s Dement. 2021;17:1056&#x2013;1065. doi: 10.1002/alz.12255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12255</ArticleId><ArticleId IdType="pmc">PMC10431934</ArticleId><ArticleId IdType="pubmed">33399270</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham E.L., Clark J.R., Orban Z.S., Lim P.H., Szymanski A.L., Taylor C., DiBiase R.M., Jia D.T., Balabanov R., Ho S.U., et al. Persistent Neurologic Symptoms and Cognitive Dysfunction in Non-Hospitalized Covid-19 &#x201c;Long Haulers&#x201d;. Ann. Clin. Transl. Neurol. 2021;8:1073&#x2013;1085. doi: 10.1002/acn3.51350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Khodanovich M.Y., Kamaeva D.A., Naumova A.V. Role of Demyelination in the Persistence of Neurological and Mental Impairments after COVID-19. Int. J. Mol. Sci. 2022;23:11291. doi: 10.3390/ijms231911291.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms231911291</ArticleId><ArticleId IdType="pmc">PMC9569975</ArticleId><ArticleId IdType="pubmed">36232592</ArticleId></ArticleIdList></Reference><Reference><Citation>Varatharaj A., Thomas N., Ellul M.A., Davies N.W.S., Pollak T.A., Tenorio E.L., Sultan M., Easton A., Breen G., Zandi M., et al. Neurological and Neuropsychiatric Complications of COVID-19 in 153 Patients: A UK-Wide Surveillance Study. Lancet Psychiatry. 2020;7:875&#x2013;882. doi: 10.1016/S2215-0366(20)30287-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30287-X</ArticleId><ArticleId IdType="pmc">PMC7316461</ArticleId><ArticleId IdType="pubmed">32593341</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskowiak K.W., Johnsen S., Sattler S.M., Nielsen S., Kunalan K., Rungby J., Lapperre T., Porsberg C.M. Cognitive Impairments Four Months after COVID-19 Hospital Discharge: Pattern, Severity and Association with Illness Variables. Eur. Neuropsychopharmacol. 2021;46:39&#x2013;48. doi: 10.1016/j.euroneuro.2021.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroneuro.2021.03.019</ArticleId><ArticleId IdType="pmc">PMC8006192</ArticleId><ArticleId IdType="pubmed">33823427</ArticleId></ArticleIdList></Reference><Reference><Citation>Daroische R., Hemminghyth M.S., Eilertsen T.H., Breitve M.H., Chwiszczuk L.J. Cognitive Impairment After COVID-19&#x2014;A Review on Objective Test Data. Front. Neurol. 2021;12:699582. doi: 10.3389/fneur.2021.699582.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.699582</ArticleId><ArticleId IdType="pmc">PMC8357992</ArticleId><ArticleId IdType="pubmed">34393978</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo M.S., Malsy J., P&#xf6;ttgen J., Seddiq Zai S., Ufer F., Hadjilaou A., Schmiedel S., Addo M.M., Gerloff C., Heesen C., et al. Frequent Neurocognitive Deficits after Recovery from Mild COVID-19. Brain Commun. 2020;2:fcaa205. doi: 10.1093/braincomms/fcaa205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa205</ArticleId><ArticleId IdType="pmc">PMC7717144</ArticleId><ArticleId IdType="pubmed">33376990</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanou M.I., Palaiodimou L., Bakola E., Smyrnis N., Papadopoulou M., Paraskevas G.P., Rizos E., Boutati E., Grigoriadis N., Krogias C., et al. Neurological Manifestations of Long-COVID Syndrome: A Narrative Review. Ther. Adv. Chronic Dis. 2022;13:1&#x2013;21. doi: 10.1177/20406223221076890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20406223221076890</ArticleId><ArticleId IdType="pmc">PMC8859684</ArticleId><ArticleId IdType="pubmed">35198136</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson C.J., Sarangi A., Bangash F. Neurological Sequelae of COVID-19: A Review. Egypt. J. Neurol. Psychiatry Neurosurg. 2021;57:122. doi: 10.1186/s41983-021-00379-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41983-021-00379-0</ArticleId><ArticleId IdType="pmc">PMC8424148</ArticleId><ArticleId IdType="pubmed">34511868</ArticleId></ArticleIdList></Reference><Reference><Citation>Efstathiou V., Stefanou M.-I., Demetriou M., Siafakas N., Makris M., Tsivgoulis G., Zoumpourlis V., Kympouropoulos S., Tsoporis J., Spandidos D., et al. Long COVID and Neuropsychiatric Manifestations (Review) Exp. Ther. Med. 2022;23:363. doi: 10.3892/etm.2022.11290.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2022.11290</ArticleId><ArticleId IdType="pmc">PMC9019760</ArticleId><ArticleId IdType="pubmed">35493431</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhola S., Trisal J., Thakur V., Kaur P., Kulshrestha S., Bhatia S.K., Kumar P. Neurological Toll of COVID-19. Neurol. Sci. 2022;43:2171&#x2013;2186. doi: 10.1007/s10072-022-05875-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-022-05875-6</ArticleId><ArticleId IdType="pmc">PMC8761097</ArticleId><ArticleId IdType="pubmed">35034236</ArticleId></ArticleIdList></Reference><Reference><Citation>Naphade P., Singh P., Rao P., Rohatgi S., Chaudhury S., Nirhale S. Psychiatric Symptoms and Fatigue in COVID-19 Survivors. Cureus. 2023;15:e45651. doi: 10.7759/cureus.45651.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.45651</ArticleId><ArticleId IdType="pmc">PMC10589455</ArticleId><ArticleId IdType="pubmed">37868517</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Al-Aly Z. Risks of Mental Health Outcomes in People with Covid-19: Cohort Study. BMJ. 2022;376:1&#x2013;13. doi: 10.1136/bmj-2021-068993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-068993</ArticleId><ArticleId IdType="pmc">PMC8847881</ArticleId><ArticleId IdType="pubmed">35172971</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonetti A., Bernardi E., Margoni S., Catinari A., Restaino A., Ieritano V., Palazzetti M., Mastrantonio F., Janiri D., Tosato M., et al. Mixed Depression in the Post-COVID-19 Syndrome: Correlation between Excitatory Symptoms in Depression and Physical Burden after COVID-19. Brain Sci. 2023;13:688. doi: 10.3390/brainsci13040688.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci13040688</ArticleId><ArticleId IdType="pmc">PMC10137109</ArticleId><ArticleId IdType="pubmed">37190653</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorkiewicz P., Waszkiewicz N. Biomarkers of Post-COVID Depression. J. Clin. Med. 2021;10:4142. doi: 10.3390/jcm10184142.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10184142</ArticleId><ArticleId IdType="pmc">PMC8470902</ArticleId><ArticleId IdType="pubmed">34575258</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z., Ruan M., Chen J., Fang Y. Major Depressive Disorder: Advances in Neuroscience Research and Translational Applications. Neurosci. Bull. 2021;37:863&#x2013;880. doi: 10.1007/s12264-021-00638-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12264-021-00638-3</ArticleId><ArticleId IdType="pmc">PMC8192601</ArticleId><ArticleId IdType="pubmed">33582959</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth G.A., Mensah G.A., Johnson C.O., Addolorato G., Ammirati E., Baddour L.M., Barengo N.C., Beaton A., Benjamin E.J., Benziger C.P., et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. J. Am. Coll. Cardiol. 2020;76:2982&#x2013;3021. doi: 10.1016/j.jacc.2020.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.11.010</ArticleId><ArticleId IdType="pmc">PMC7755038</ArticleId><ArticleId IdType="pubmed">33309175</ArticleId></ArticleIdList></Reference><Reference><Citation>Braga J., Lepra M., Kish S.J., Rusjan P.M., Nasser Z., Verhoeff N., Vasdev N., Bagby M., Boileau I., Husain M.I., et al. Neuroinflammation after COVID-19 with Persistent Depressive and Cognitive Symptoms. JAMA Psychiatry. 2023;80:787&#x2013;795. doi: 10.1001/jamapsychiatry.2023.1321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2023.1321</ArticleId><ArticleId IdType="pmc">PMC10233457</ArticleId><ArticleId IdType="pubmed">37256580</ArticleId></ArticleIdList></Reference><Reference><Citation>Sriwastava S., Tandon M., Podury S., Prasad A., Wen S., Guthrie G., Kakara M., Jaiswal S., Subedi R., Elkhooly M., et al. COVID-19 and Neuroinflammation: A Literature Review of Relevant Neuroimaging and CSF Markers in Central Nervous System Inflammatory Disorders from SARS-CoV2. J. Neurol. 2021;268:4448&#x2013;4478. doi: 10.1007/s00415-021-10611-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10611-9</ArticleId><ArticleId IdType="pmc">PMC8131883</ArticleId><ArticleId IdType="pubmed">34009454</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman T.W., Hill R.A. Myelin Plasticity in Adulthood and Aging. Neurosci. Lett. 2020;715:134645. doi: 10.1016/j.neulet.2019.134645.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2019.134645</ArticleId><ArticleId IdType="pmc">PMC6981290</ArticleId><ArticleId IdType="pubmed">31765728</ArticleId></ArticleIdList></Reference><Reference><Citation>Sams E.C. Oligodendrocytes in the Aging Brain. Neuronal Signal. 2021;5:NS20210008. doi: 10.1042/NS20210008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/NS20210008</ArticleId><ArticleId IdType="pmc">PMC8264650</ArticleId><ArticleId IdType="pubmed">34290887</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohama S.G., Rosene D.L., Sherman L.S. Age-Related Changes in Human and Non-Human Primate White Matter: From Myelination Disturbances to Cognitive Decline. Age. 2012;34:1093&#x2013;1110. doi: 10.1007/s11357-011-9357-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-011-9357-7</ArticleId><ArticleId IdType="pmc">PMC3448998</ArticleId><ArticleId IdType="pubmed">22203458</ArticleId></ArticleIdList></Reference><Reference><Citation>Faro S.H., Manmatharayan A., Leiby B., Jain N., Mohamed F.B., Talekar K.S., Doshi A., Jambor I., Chang S., Finkelstein M., et al. Neuroimaging Findings in 4342 Hospitalized COVID-19 Subjects: A Multicenter Report from the United States and Europe. J. Neuroimaging. 2023;33:752&#x2013;763. doi: 10.1111/jon.13140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jon.13140</ArticleId><ArticleId IdType="pubmed">37381160</ArticleId></ArticleIdList></Reference><Reference><Citation>Erdo&#x11f;an T., Ko&#xe7;er B., &#x15e;en S., Petek Balci B., Terzi M. Newly Diagnosed Tumefactive Demyelinating Lesion and Multiple Sclerosis after COVID-19 Infection. Noropsikiyatri Ars. 2023;60:223&#x2013;230. doi: 10.29399/npa.28142.</Citation><ArticleIdList><ArticleId IdType="doi">10.29399/npa.28142</ArticleId><ArticleId IdType="pmc">PMC10461761</ArticleId><ArticleId IdType="pubmed">37645083</ArticleId></ArticleIdList></Reference><Reference><Citation>Bezold A., Hussain H., Nwanze J., Roberts J.T., Hsieh K.J. Radiologic-Pathologic Correlation of COVID-19-Associated Acute Disseminated Encephalomyelitis. Cureus. 2023;15:e42275. doi: 10.7759/cureus.42275.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.42275</ArticleId><ArticleId IdType="pmc">PMC10440160</ArticleId><ArticleId IdType="pubmed">37605696</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma V., Chhabra T., Singh T.G. Correlation of Covid-19 and Guillain-Barr&#xe9; Syndrome: A Mechanistic Perspective. Obes. Med. 2023;40:100493. doi: 10.1016/j.obmed.2023.100493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.obmed.2023.100493</ArticleId><ArticleId IdType="pmc">PMC10091783</ArticleId><ArticleId IdType="pubmed">37131407</ArticleId></ArticleIdList></Reference><Reference><Citation>Malekpour M., Khanmohammadi S., Meybodi M.J.E., Shekouh D., Rahmanian M.R., Kardeh S., Azarpira N. COVID-19 as a Trigger of Guillain-Barr&#xe9; Syndrome: A Review of the Molecular Mechanism. Immun. Inflamm. Dis. 2023;11:e875. doi: 10.1002/iid3.875.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iid3.875</ArticleId><ArticleId IdType="pmc">PMC10187022</ArticleId><ArticleId IdType="pubmed">37249286</ArticleId></ArticleIdList></Reference><Reference><Citation>Sklinda K., Dorobek M., Wasilewski P.G., Dre&#x17c;ewski K., D&#x229;bicka M., Walecki J., Mruk B. Radiological Manifestation of Neurological Complications in the Course of SARS-CoV-2 Infection. Front. Neurol. 2021;12:711026. doi: 10.3389/fneur.2021.711026.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.711026</ArticleId><ArticleId IdType="pmc">PMC8563625</ArticleId><ArticleId IdType="pubmed">34744963</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhardwaj A., Mishra H.P., Goel A., Gupta A. COVID-19&#x2014;A Potential Trigger for MOGAD-Associated Optic Neuritis: A Case Report and Literature Review. Ther. Adv. Ophthalmol. 2023;15:1&#x2013;9. doi: 10.1177/25158414231199541.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/25158414231199541</ArticleId><ArticleId IdType="pmc">PMC10559697</ArticleId><ArticleId IdType="pubmed">37808590</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S., Zhou X., Zhao W., Du Y., Yang D., Huang Y., Chen Y., Zhang H., Yang G., Liu J., et al. Dynamic White Matter Changes in Recovered COVID-19 Patients: A Two-Year Follow-up Study. Theranostics. 2023;13:724&#x2013;735. doi: 10.7150/thno.79902.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.79902</ArticleId><ArticleId IdType="pmc">PMC9830428</ArticleId><ArticleId IdType="pubmed">36632218</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S., Zhou Z., Yang D., Zhao W., Zeng M., Xie X., Du Y., Jiang Y., Zhou X., Yang W., et al. Persistent White Matter Changes in Recovered COVID-19 Patients at the 1-Year Follow-Up. Brain. 2022;145:1830&#x2013;1838. doi: 10.1093/brain/awab435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab435</ArticleId><ArticleId IdType="pmc">PMC8754808</ArticleId><ArticleId IdType="pubmed">34918020</ArticleId></ArticleIdList></Reference><Reference><Citation>Bispo D.D.d.C., Brand&#xe3;o P.R.d.P., Pereira D.A., Maluf F.B., Dias B.A., Paranhos H.R., von Glehn F., de Oliveira A.C.P., Regattieri N.A.T., Silva L.S., et al. Brain Microstructural Changes and Fatigue after COVID-19. Front. Neurol. 2022;13:1029302. doi: 10.3389/fneur.2022.1029302.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.1029302</ArticleId><ArticleId IdType="pmc">PMC9685991</ArticleId><ArticleId IdType="pubmed">36438956</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedetti F., Palladini M., Paolini M., Melloni E., Vai B., De Lorenzo R., Furlan R., Rovere-Querini P., Falini A., Mazza M.G. Brain Correlates of Depression, Post-Traumatic Distress, and Inflammatory Biomarkers in COVID-19 Survivors: A Multimodal Magnetic Resonance Imaging Study. Brain Behav. Immun.&#x2014;Health. 2021;18:100387. doi: 10.1016/j.bbih.2021.100387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2021.100387</ArticleId><ArticleId IdType="pmc">PMC8562046</ArticleId><ArticleId IdType="pubmed">34746876</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Y., Wu J., Chen T., Li J., Zhang G., Wu D., Zhou Y., Zheng N., Cai A., Ning Q., et al. Long-Term Microstructure and Cerebral Blood Flow Changes in Patients Recovered from COVID-19 without Neurological Manifestations. J. Clin. Investig. 2021;131:e147329. doi: 10.1172/JCI147329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI147329</ArticleId><ArticleId IdType="pmc">PMC8262559</ArticleId><ArticleId IdType="pubmed">33630760</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian T., Wu J., Chen T., Li J., Yan S., Zhou Y., Peng X., Li Y., Zheng N., Cai A., et al. Long-Term Follow-up of Dynamic Brain Changes in Patients Recovered from COVID-19 without Neurological Manifestations. JCI Insight. 2022;7:e155827. doi: 10.1172/jci.insight.155827.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.155827</ArticleId><ArticleId IdType="pmc">PMC8876627</ArticleId><ArticleId IdType="pubmed">35191397</ArticleId></ArticleIdList></Reference><Reference><Citation>Boito D., Eklund A., Tisell A., Levi R., &#xd6;zarslan E., Blystad I. MRI with Generalized Diffusion Encoding Reveals Damaged White Matter in Patients Previously Hospitalized for COVID-19 and with Persisting Symptoms at Follow-Up. Brain Commun. 2023;5:fcad284. doi: 10.1093/braincomms/fcad284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcad284</ArticleId><ArticleId IdType="pmc">PMC10638510</ArticleId><ArticleId IdType="pubmed">37953843</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza M.G., Palladini M., Poletti S., Benedetti F. Post-COVID-19 Depressive Symptoms: Epidemiology, Pathophysiology, and Pharmacological Treatment. CNS Drugs. 2022;36:681&#x2013;702. doi: 10.1007/s40263-022-00931-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40263-022-00931-3</ArticleId><ArticleId IdType="pmc">PMC9210800</ArticleId><ArticleId IdType="pubmed">35727534</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise T., Marwood L., Perkins A.M., Herane-Vives A., Joules R., Lythgoe D.J., Luh W.M., Williams S.C.R., Young A.H., Cleare A.J., et al. Instability of Default Mode Network Connectivity in Major Depression: A Two-Sample Confirmation Study. Transl. Psychiatry. 2017;7:e1105. doi: 10.1038/tp.2017.40.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/tp.2017.40</ArticleId><ArticleId IdType="pmc">PMC5416685</ArticleId><ArticleId IdType="pubmed">28440813</ArticleId></ArticleIdList></Reference><Reference><Citation>van Velzen L.S., Kelly S., Isaev D., Aleman A., Aftanas L.I., Bauer J., Baune B.T., Brak I.V., Carballedo A., Connolly C.G., et al. White Matter Disturbances in Major Depressive Disorder: A Coordinated Analysis across 20 International Cohorts in the ENIGMA MDD Working Group. Mol. Psychiatry. 2020;25:1511&#x2013;1525. doi: 10.1038/s41380-019-0477-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-019-0477-2</ArticleId><ArticleId IdType="pmc">PMC7055351</ArticleId><ArticleId IdType="pubmed">31471575</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou G., Lai W., Jiang W., Liu X., Qian L., Zhang Y., Zhou Z. Myelin Deficits in Patients with Recurrent Major Depressive Disorder: An Inhomogeneous Magnetization Transfer Study. Neurosci. Lett. 2021;750:135768. doi: 10.1016/j.neulet.2021.135768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2021.135768</ArticleId><ArticleId IdType="pubmed">33636288</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacchet M.D., Gotlib I.H. Myelination of the Brain in Major Depressive Disorder: An in Vivo Quantitative Magnetic Resonance Imaging Study. Sci. Rep. 2017;7:2200. doi: 10.1038/s41598-017-02062-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-02062-y</ArticleId><ArticleId IdType="pmc">PMC5438403</ArticleId><ArticleId IdType="pubmed">28526817</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai C.H., Wu Y. Te The White Matter Microintegrity Alterations of Neocortical and Limbic Association Fibers in Major Depressive Disorder and Panic Disorder: The Comparison. Medicine. 2016;95:e2982. doi: 10.1097/MD.0000000000002982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000002982</ArticleId><ArticleId IdType="pmc">PMC4782901</ArticleId><ArticleId IdType="pubmed">26945417</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Y., Huang X., Wu Q., Yang C., Kuang W., Du M., Lui S., Yue Q., Chan R.C.K., Kemp G.J., et al. Is Depression a Disconnection Syndrome? Meta-Analysis of Diffusion Tensor Imaging Studies in Patients with MDD. J. Psychiatry Neurosci. 2013;38:49&#x2013;56. doi: 10.1503/jpn.110180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/jpn.110180</ArticleId><ArticleId IdType="pmc">PMC3529219</ArticleId><ArticleId IdType="pubmed">22691300</ArticleId></ArticleIdList></Reference><Reference><Citation>Coloigner J., Batail J.M., Commowick O., Corouge I., Robert G., Barillot C., Drapier D. White Matter Abnormalities in Depression: A Categorical and Phenotypic Diffusion MRI Study. NeuroImage Clin. 2019;22:101710. doi: 10.1016/j.nicl.2019.101710.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2019.101710</ArticleId><ArticleId IdType="pmc">PMC6406626</ArticleId><ArticleId IdType="pubmed">30849644</ArticleId></ArticleIdList></Reference><Reference><Citation>Trujillo P., Summers P.E., Ferrari E., Zucca F.A., Sturini M., Mainardi L.T., Cerutti S., Smith A.K., Smith S.A., Zecca L., et al. Contrast Mechanisms Associated with Neuromelanin-MRI. Magn. Reson. Med. 2017;78:1790&#x2013;1800. doi: 10.1002/mrm.26584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.26584</ArticleId><ArticleId IdType="pubmed">28019018</ArticleId></ArticleIdList></Reference><Reference><Citation>Li K., Li H., Zhang X.Y., Stokes A.M., Jiang X., Kang H., Quarles C.C., Zu Z., Gochberg D.F., Gore J.C., et al. Influence of Water Compartmentation and Heterogeneous Relaxation on Quantitative Magnetization Transfer Imaging in Rodent Brain Tumors. Magn. Reson. Med. 2016;76:635&#x2013;644. doi: 10.1002/mrm.25893.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.25893</ArticleId><ArticleId IdType="pmc">PMC4794427</ArticleId><ArticleId IdType="pubmed">26375875</ArticleId></ArticleIdList></Reference><Reference><Citation>Yarnykh V.L., Krutenkova E.P., Aitmagambetova G., Henson L.K.J., Piedmont H., Repovic P., Mayadev A., Qian P., Gangadharan B. Iron-Insensitive Quantitative Assessment of Subcortical Gray Matter Demyelination in Multiple Sclerosis Using Macromolecular Proton Fraction. Am. J. Neuroradiol. 2018;39:618&#x2013;625. doi: 10.3174/ajnr.A5542.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A5542</ArticleId><ArticleId IdType="pmc">PMC5895485</ArticleId><ArticleId IdType="pubmed">29439122</ArticleId></ArticleIdList></Reference><Reference><Citation>Khodanovich M.Y.Y., Sorokina I.V.V., Glazacheva V.Y.Y., Akulov A.E.E., Nemirovich-Danchenko N.M.M., Romashchenko A.V.V., Tolstikova T.G.G., Mustafina L.R.R., Yarnykh V.L.L. Histological Validation of Fast Macromolecular Proton Fraction Mapping as a Quantitative Myelin Imaging Method in the Cuprizone Demyelination Model. Sci. Rep. 2017;7:46686. doi: 10.1038/srep46686.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep46686</ArticleId><ArticleId IdType="pmc">PMC5402392</ArticleId><ArticleId IdType="pubmed">28436460</ArticleId></ArticleIdList></Reference><Reference><Citation>Khodanovich M.Y., Pishchelko A.O., Glazacheva V.Y., Pan E.S., Akulov A.E., Svetlik M.V., Tyumentseva Y.A., Anan&#x2019;ina T.V., Leonidovich Y.V. Quantitative Imaging of White and Gray Matter Remyelination in the Cuprizone Demyelination Model Using the Macromolecular Proton Fraction. Cells. 2019;8:1204. doi: 10.3390/cells8101204.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8101204</ArticleId><ArticleId IdType="pmc">PMC6830095</ArticleId><ArticleId IdType="pubmed">31590363</ArticleId></ArticleIdList></Reference><Reference><Citation>Khodanovich M.Y., Gubskiy I.L., Kudabaeva M.S., Namestnikova D.D., Kisel A.A., Anan&#x2019;ina T.V., Tumentceva Y.A., Mustafina L.R., Yarnykh V.L. Long-Term Monitoring of Chronic Demyelination and Remyelination in a Rat Ischemic Stroke Model Using Macromolecular Proton Fraction Mapping. J. Cereb. Blood Flow Metab. 2021;41:2856&#x2013;2869. doi: 10.1177/0271678X211020860.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0271678X211020860</ArticleId><ArticleId IdType="pmc">PMC8756474</ArticleId><ArticleId IdType="pubmed">34107787</ArticleId></ArticleIdList></Reference><Reference><Citation>Khodanovich M.Y., Kisel A.A., Akulov A.E., Atochin D.N., Kudabaeva M.S., Glazacheva V.Y., Svetlik M.V., Medvednikova Y.A., Mustafina L.R., Yarnykh V.L. Quantitative Assessment of Demyelination in Ischemic Stroke in Vivo Using Macromolecular Proton Fraction Mapping. J. Cereb. Blood Flow Metab. 2018;38:919&#x2013;931. doi: 10.1177/0271678X18755203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0271678X18755203</ArticleId><ArticleId IdType="pmc">PMC5987939</ArticleId><ArticleId IdType="pubmed">29372644</ArticleId></ArticleIdList></Reference><Reference><Citation>Kisel A.A., Naumova A.V., Yarnykh V.L. Macromolecular Proton Fraction as a Myelin Biomarker: Principles, Validation, and Applications. Front. Neurosci. 2022;16:819912. doi: 10.3389/fnins.2022.819912.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2022.819912</ArticleId><ArticleId IdType="pmc">PMC8863973</ArticleId><ArticleId IdType="pubmed">35221905</ArticleId></ArticleIdList></Reference><Reference><Citation>Naumova A.V., Akulov A.E., Khodanovich M.Y., Yarnykh V.L. High-Resolution Three-Dimensional Macromolecular Proton Fraction Mapping for Quantitative Neuroanatomical Imaging of the Rodent Brain in Ultra-High Magnetic Fields. Neuroimage. 2017;147:985&#x2013;993. doi: 10.1016/j.neuroimage.2016.09.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2016.09.036</ArticleId><ArticleId IdType="pmc">PMC5303642</ArticleId><ArticleId IdType="pubmed">27646128</ArticleId></ArticleIdList></Reference><Reference><Citation>Anisimov N.V., Pavlova O.S., Pirogov Y.A., Leonidovich Y.V. Three-Dimensional Fast Single-Point Macromolecular Proton Fraction Mapping of the Human Brain at 0.5 Tesla. Quant. Imaging Med. Surg. 2020;10:1441&#x2013;1449. doi: 10.21037/qims-19-1057.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/qims-19-1057</ArticleId><ArticleId IdType="pmc">PMC7358422</ArticleId><ArticleId IdType="pubmed">32676363</ArticleId></ArticleIdList></Reference><Reference><Citation>Smirnova L.P., Yarnykh V.L., Parshukova D.A., Kornetova E.G., Semke A.V., Usova A.V., Pishchelko A.O., Khodanovich M.Y., Ivanova S.A. Global Hypomyelination of the Brain White and Gray Matter in Schizophrenia: Quantitative Imaging Using Macromolecular Proton Fraction. Transl. Psychiatry. 2021;11:365. doi: 10.1038/s41398-021-01475-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-021-01475-8</ArticleId><ArticleId IdType="pmc">PMC8257619</ArticleId><ArticleId IdType="pubmed">34226491</ArticleId></ArticleIdList></Reference><Reference><Citation>Yarnykh V.L.L., Prihod&#x2019;ko I.Y.Y., Savelov A.A.A., Korostyshevskaya A.M.M. Quantitative Assessment of Normal Fetal Brain Myelination Using Fast Macromolecular Proton Fraction Mapping. Am. J. Neuroradiol. 2018;39:1341&#x2013;1348. doi: 10.3174/ajnr.A5668.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A5668</ArticleId><ArticleId IdType="pmc">PMC7655450</ArticleId><ArticleId IdType="pubmed">29748201</ArticleId></ArticleIdList></Reference><Reference><Citation>Korostyshevskaya A.M.M., Prihod&#x2019;ko I.Y.Y., Savelov A.A.A., Yarnykh V.L.L. Direct Comparison between Apparent Diffusion Coefficient and Macromolecular Proton Fraction as Quantitative Biomarkers of the Human Fetal Brain Maturation. J. Magn. Reson. Imaging. 2019;50:52&#x2013;61. doi: 10.1002/jmri.26635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmri.26635</ArticleId><ArticleId IdType="pmc">PMC6579650</ArticleId><ArticleId IdType="pubmed">30635965</ArticleId></ArticleIdList></Reference><Reference><Citation>Janca A., Ust&#xfc;n T.B., Early T.S., Sartorius N. The ICD-10 Symptom Checklist: A Companion to the ICD-10 Classification of Mental and Behavioural Disorders. Soc. Psychiatry Psychiatr. Epidemiol. 1993;28:239&#x2013;242. doi: 10.1007/BF00788743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00788743</ArticleId><ArticleId IdType="pubmed">8284737</ArticleId></ArticleIdList></Reference><Reference><Citation>Zigmond A.S., Snaith R.P. The Hospital Anxiety and Depression Scale. Acta Psychiatr. Scand. 1983;67:361&#x2013;370. doi: 10.1111/j.1600-0447.1983.tb09716.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0447.1983.tb09716.x</ArticleId><ArticleId IdType="pubmed">6880820</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton M. A Rating Scale for Depression. J. Neurol. Neurosurg. Psychiatry. 1960;23:56&#x2013;62. doi: 10.1136/jnnp.23.1.56.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.23.1.56</ArticleId><ArticleId IdType="pmc">PMC495331</ArticleId><ArticleId IdType="pubmed">14399272</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton M. Development of a Rating Scale for Depressive Illness. Br. J. Soc. Clin. Psychol. 1967;6:278&#x2013;296. doi: 10.1111/j.2044-8260.1967.tb00530.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2044-8260.1967.tb00530.x</ArticleId><ArticleId IdType="pubmed">6080235</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan Sui Ko A., Candellier A., Mercier M., Joseph C., Schmit J.L., Lanoix J.P., Andrejak C. Number of Initial Symptoms Is More Related to Long COVID-19 than Acute Severity of Infection: A Prospective Cohort of Hospitalized Patients. Int. J. Infect. Dis. 2022;118:220&#x2013;223. doi: 10.1016/j.ijid.2022.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.03.006</ArticleId><ArticleId IdType="pmc">PMC8896858</ArticleId><ArticleId IdType="pubmed">35257903</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Pellicer-Valero O.J., Navarro-Pardo E., Rodr&#xed;guez-Jim&#xe9;nez J., Mart&#xed;n-Guerrero J.D., Cigar&#xe1;n-M&#xe9;ndezd M. The Number of Symptoms at the Acute COVID-19 Phase Is Associated with Anxiety and Depressive Long-Term Post-COVID Symptoms: A Multicenter Study. J. Psychosom. Res. 2021;150:110625. doi: 10.1016/j.jpsychores.2021.110625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2021.110625</ArticleId><ArticleId IdType="pmc">PMC8455234</ArticleId><ArticleId IdType="pubmed">34563747</ArticleId></ArticleIdList></Reference><Reference><Citation>Durstenfeld M.S., Peluso M.J., Peyser N.D., Lin F., Knight S.J., Djibo A., Khatib R., Kitzman H., O&#x2019;Brien E., Williams N., et al. Factors Associated with Long COVID Symptoms in an Online Cohort Study. Open Forum Infect. Dis. 2023;10:ofad047. doi: 10.1093/ofid/ofad047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofad047</ArticleId><ArticleId IdType="pmc">PMC9945931</ArticleId><ArticleId IdType="pubmed">36846611</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya A.A., Akbari A., Emami A., Lotfi M., Rostamihosseinkhani M., Nemati H., Barzegar Z., Kabiri M., Zeraatpisheh Z., Farjoud-Kouhanjani M., et al. Risk Factors Associated with Long Covid Syndrome: A Retrospective Study. Iran. J. Med. Sci. 2021;46:428&#x2013;436. doi: 10.30476/ijms.2021.92080.2326.</Citation><ArticleIdList><ArticleId IdType="doi">10.30476/ijms.2021.92080.2326</ArticleId><ArticleId IdType="pmc">PMC8611223</ArticleId><ArticleId IdType="pubmed">34840383</ArticleId></ArticleIdList></Reference><Reference><Citation>Yarnykh V.L. Time-Efficient, High-Resolution, Whole Brain Three-Dimensional Macromolecular Proton Fraction Mapping. Magn. Reson. Med. 2016;75:2100&#x2013;2106. doi: 10.1002/mrm.25811.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.25811</ArticleId><ArticleId IdType="pmc">PMC4688249</ArticleId><ArticleId IdType="pubmed">26102097</ArticleId></ArticleIdList></Reference><Reference><Citation>Yarnykh V.L., Tartaglione E.V., Ioannou G.N. Fast Macromolecular Proton Fraction Mapping of the Human Liver in Vivo for Quantitative Assessment of Hepatic Fibrosis. NMR Biomed. 2015;28:1716&#x2013;1725. doi: 10.1002/nbm.3437.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nbm.3437</ArticleId><ArticleId IdType="pmc">PMC4715674</ArticleId><ArticleId IdType="pubmed">26503401</ArticleId></ArticleIdList></Reference><Reference><Citation>Avants B.B., Tustison N.J., Song G., Cook P.A., Klein A., Gee J.C. NeuroImage A Reproducible Evaluation of ANTs Similarity Metric Performance in Brain Image Registration. Neuroimage. 2011;54:2033&#x2013;2044. doi: 10.1016/j.neuroimage.2010.09.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2010.09.025</ArticleId><ArticleId IdType="pmc">PMC3065962</ArticleId><ArticleId IdType="pubmed">20851191</ArticleId></ArticleIdList></Reference><Reference><Citation>Avants B.B., Yushkevich P., Pluta J., Minkoff D., Korczykowski M., Detre J., Gee J.C. NeuroImage The Optimal Template Effect in Hippocampus Studies of Diseased Populations. Neuroimage. 2010;49:2457&#x2013;2466. doi: 10.1016/j.neuroimage.2009.09.062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2009.09.062</ArticleId><ArticleId IdType="pmc">PMC2818274</ArticleId><ArticleId IdType="pubmed">19818860</ArticleId></ArticleIdList></Reference><Reference><Citation>Oishi K., Faria A., Jiang H., Li X., Akhter K., Zhang J., Hsu J.T., Miller M.I., Van Zijl P.C.M., Albert M., et al. NeuroImage Atlas-Based Whole Brain White Matter Analysis Using Large Deformation Diffeomorphic Metric Mapping: Application to Normal Elderly and Alzheimer&#x2019; s Disease Participants. Neuroimage. 2009;46:486&#x2013;499. doi: 10.1016/j.neuroimage.2009.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2009.01.002</ArticleId><ArticleId IdType="pmc">PMC2885858</ArticleId><ArticleId IdType="pubmed">19385016</ArticleId></ArticleIdList></Reference><Reference><Citation>Khodanovich M., Svetlik M., Naumova A., Kamaeva D., Usova A., Kudabaeva M., Wasserlauf I., Pashkevich V., Moshkina M., Obukhovskaya V., et al. Age-Related Decline in Brain Myelination: Quantitative Macromolecular Proton Fraction Mapping, T2-FLAIR Hyperintensity Volume, and Anti-Myelin Antibodies 7 Years Apart. Biomedicines. 2023:preprint. doi: 10.3390/biomedicines12010061.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines12010061</ArticleId><ArticleId IdType="pmc">PMC10812983</ArticleId><ArticleId IdType="pubmed">38255168</ArticleId></ArticleIdList></Reference><Reference><Citation>Porritt M.T. Performance of Number of Factors Procedures in Small Sample Sizes. Loma Linda University; Loma Linda, CA, USA: 2015.</Citation></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and Predictors of Long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-Month Consequences of COVID-19 in Patients Discharged from Hospital: A Cohort Study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahmer T., Borzikowsky C., Lieb W., Horn A., Krist L., Fricke J., Scheibenbogen C., Rabe K.F., Maetzler W., Maetzler C., et al. Severity, Predictors and Clinical Correlates of Post-COVID Syndrome (PCS) in Germany: A Prospective, Multi-Centre, Population-Based Cohort Study. EClinicalMedicine. 2022;51:101549. doi: 10.1016/j.eclinm.2022.101549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101549</ArticleId><ArticleId IdType="pmc">PMC9289961</ArticleId><ArticleId IdType="pubmed">35875815</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilotto A., Cristillo V., Cotti Piccinelli S., Zoppi N., Bonzi G., Sattin D., Schiavolin S., Raggi A., Canale A., Gipponi S., et al. Long-Term Neurological Manifestations of COVID-19: Prevalence and Predictive Factors. Neurol. Sci. 2021;42:4903&#x2013;4907. doi: 10.1007/s10072-021-05586-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05586-4</ArticleId><ArticleId IdType="pmc">PMC8439956</ArticleId><ArticleId IdType="pubmed">34523082</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao L., Han G., Zhao Y., Jin Y., Ge T., Yang W., Cui R., Xu S., Li B. Gender Differences in Depression: Evidence From Genetics. Front. Genet. 2020;11:562316. doi: 10.3389/fgene.2020.562316.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2020.562316</ArticleId><ArticleId IdType="pmc">PMC7593575</ArticleId><ArticleId IdType="pubmed">33193645</ArticleId></ArticleIdList></Reference><Reference><Citation>Labaka A., Go&#xf1;i-Balentziaga O., Lebe&#xf1;a A., P&#xe9;rez-Tejada J. Biological Sex Differences in Depression: A Systematic Review. Biol. Res. Nurs. 2018;20:383&#x2013;392. doi: 10.1177/1099800418776082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1099800418776082</ArticleId><ArticleId IdType="pubmed">29759000</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortona E., Malorni W. Long COVID: To Investigate Immunological Mechanisms and Sex/Gender Related Aspects as Fundamental Steps for a Tailored Therapy. Eur. Respir. J. 2022;59:2102245. doi: 10.1183/13993003.02245-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02245-2021</ArticleId><ArticleId IdType="pmc">PMC8462012</ArticleId><ArticleId IdType="pubmed">34531277</ArticleId></ArticleIdList></Reference><Reference><Citation>Taslem Mourosi J., Anwar S., Hosen M.J. The Sex and Gender Dimensions of COVID-19: A Narrative Review of the Potential Underlying Factors. Infect. Genet. Evol. 2022;103:105338. doi: 10.1016/j.meegid.2022.105338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2022.105338</ArticleId><ArticleId IdType="pmc">PMC9288935</ArticleId><ArticleId IdType="pubmed">35863677</ArticleId></ArticleIdList></Reference><Reference><Citation>Khodanovich M., Naumova A., Kamaeva D., Obukhovskaya V., Vasilieva S., Schastnyy E., Kataeva N., Levina A., Kudabaeva M., Pashkevich V., et al. Neurocognitive Changes in Patients with Post-COVID Depression. J. Clin. Med. 2024;13:1442. doi: 10.3390/jcm13051442.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm13051442</ArticleId><ArticleId IdType="pmc">PMC10933987</ArticleId><ArticleId IdType="pubmed">38592295</ArticleId></ArticleIdList></Reference><Reference><Citation>Caverzasi E., Papinutto N., Amirbekian B., Berger M.S., Henry R.G. Q-Ball of Inferior Fronto-Occipital Fasciculus and Beyond. PLoS ONE. 2014;9:e100274. doi: 10.1371/journal.pone.0100274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0100274</ArticleId><ArticleId IdType="pmc">PMC4063757</ArticleId><ArticleId IdType="pubmed">24945305</ArticleId></ArticleIdList></Reference><Reference><Citation>Conner A.K., Briggs R.G., Sali G., Rahimi M., Baker C.M., Burks J.D., Glenn C.A., Battiste J.D., Sughrue M.E. A Connectomic Atlas of the Human Cerebrum-Chapter 13: Tractographic Description of the Inferior Fronto-Occipital Fasciculus. Oper. Neurosurg. 2018;15:5436&#x2013;5443. doi: 10.1093/ons/opy267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ons/opy267</ArticleId><ArticleId IdType="pmc">PMC6890527</ArticleId><ArticleId IdType="pubmed">30260438</ArticleId></ArticleIdList></Reference><Reference><Citation>Hausman H.K., Hardcastle C., Albizu A., Kraft J.N., Evangelista N.D., Boutzoukas E.M., Langer K., O&#x2019;Shea A., Van Etten E.J., Bharadwaj P.K., et al. Cingulo-Opercular and Frontoparietal Control Network Connectivity and Executive Functioning in Older Adults. GeroScience. 2022;44:847&#x2013;866. doi: 10.1007/s11357-021-00503-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-021-00503-1</ArticleId><ArticleId IdType="pmc">PMC9135913</ArticleId><ArticleId IdType="pubmed">34950997</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Sun D., Wang Y., Wang Y. Subcomponents and Connectivity of the Inferior Fronto-Occipital Fasciculus Revealed by Diffusion Spectrum Imaging Fiber Tracking. Front. Neuroanat. 2016;10:88. doi: 10.3389/fnana.2016.00088.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnana.2016.00088</ArticleId><ArticleId IdType="pmc">PMC5033953</ArticleId><ArticleId IdType="pubmed">27721745</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F., Pievani M., Sala S., Geroldi C., Galluzzi S., Frisoni G.B., Filippi M. White Matter Damage in Alzheimer Disease and Its Relationship to Gray Matter Atrophy. Radiology. 2011;258:853&#x2013;863. doi: 10.1148/radiol.10101284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.10101284</ArticleId><ArticleId IdType="pubmed">21177393</ArticleId></ArticleIdList></Reference><Reference><Citation>Waller R., Dotterer H.L., Murray L., Maxwell A.M., Hyde L.W. White-Matter Tract Abnormalities and Antisocial Behavior: A Systematic Review of Diffusion Tensor Imaging Studies across Development. NeuroImage Clin. 2017;14:201&#x2013;215. doi: 10.1016/j.nicl.2017.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2017.01.014</ArticleId><ArticleId IdType="pmc">PMC5280002</ArticleId><ArticleId IdType="pubmed">28180079</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng Z.W., Lui S.S.Y., Cheung E.F.C., Jin Z., Miao G.D., Jing J., Chan R.C.K. Brain Structural Abnormalities in Obsessive-Compulsive Disorder: Converging Evidence from White Matter and Grey Matter. Asian J. Psychiatr. 2012;5:290&#x2013;296. doi: 10.1016/j.ajp.2012.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajp.2012.07.004</ArticleId><ArticleId IdType="pubmed">23174435</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y., Xu J., Yu H., Nie B., Li N., Luo C., Li H., Liu F., Bai Y., Shan B., et al. Delineation of Early and Later Adult Onset Depression by Diffusion Tensor Imaging. PLoS ONE. 2014;9:e112307. doi: 10.1371/journal.pone.0112307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0112307</ArticleId><ArticleId IdType="pmc">PMC4231105</ArticleId><ArticleId IdType="pubmed">25393297</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang S., Wang Q., Kong X., Deng W., Yang X., Li X., Zhang Z., Zhang J., Zhang C., Li X.M., et al. White Matter Abnormalities in Major Depression Biotypes Identified by Diffusion Tensor Imaging. Neurosci. Bull. 2019;35:867&#x2013;876. doi: 10.1007/s12264-019-00381-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12264-019-00381-w</ArticleId><ArticleId IdType="pmc">PMC6754492</ArticleId><ArticleId IdType="pubmed">31062333</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams M.R., Sharma P., Macdonald C., Pearce R.K.B., Hirsch S.R., Maier M. Axonal Myelin Decrease in the Splenium in Major Depressive Disorder. Eur. Arch. Psychiatry Clin. Neurosci. 2019;269:387&#x2013;395. doi: 10.1007/s00406-018-0904-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00406-018-0904-4</ArticleId><ArticleId IdType="pmc">PMC6525661</ArticleId><ArticleId IdType="pubmed">29980921</ArticleId></ArticleIdList></Reference><Reference><Citation>Baranger D.A.A., Halchenko Y.O., Satz S., Ragozzino R., Iyengar S., Swartz H.A., Manelis A. Aberrant Levels of Cortical Myelin Distinguish Individuals with Depressive Disorders from Healthy Controls. NeuroImage Clin. 2021;32:102790. doi: 10.1016/j.nicl.2021.102790.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2021.102790</ArticleId><ArticleId IdType="pmc">PMC8406024</ArticleId><ArticleId IdType="pubmed">34455188</ArticleId></ArticleIdList></Reference><Reference><Citation>Reppermund S., Zhuang L., Wen W., Slavin M.J., Trollor J.N., Brodaty H., Sachdev P.S. White Matter Integrity and Late-Life Depression in Community-Dwelling Individuals: Diffusion Tensor Imaging Study Using Tract-Based Spatial Statistics. Br. J. Psychiatry. 2014;205:315&#x2013;320. doi: 10.1192/bjp.bp.113.142109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.bp.113.142109</ArticleId><ArticleId IdType="pubmed">25147370</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollocks M.J., Lawrence A.J., Brookes R.L., Barrick T.R., Morris R.G., Husain M., Markus H.S. Differential Relationships between Apathy and Depression with White Matter Microstructural Changes and Functional Outcomes. Brain. 2015;138:3803&#x2013;3815. doi: 10.1093/brain/awv304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awv304</ArticleId><ArticleId IdType="pmc">PMC4655344</ArticleId><ArticleId IdType="pubmed">26490330</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J.Y., Zhang Y., Wu W.B., Hu G., Xu Y. Impaired Long Contact White Matter Fibers Integrity Is Related to Depression in Parkinson&#x2019;s Disease. CNS Neurosci. Ther. 2018;24:108&#x2013;114. doi: 10.1111/cns.12778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.12778</ArticleId><ArticleId IdType="pmc">PMC6489851</ArticleId><ArticleId IdType="pubmed">29125694</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen X., Reus L.M., Cox S.R., Adams M.J., Liewald D.C., Bastin M.E., Smith D.J., Deary I.J., Whalley H.C., McIntosh A.M. Subcortical Volume and White Matter Integrity Abnormalities in Major Depressive Disorder: Findings from UK Biobank Imaging Data. Sci. Rep. 2017;7:5547. doi: 10.1038/s41598-017-05507-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-05507-6</ArticleId><ArticleId IdType="pmc">PMC5514104</ArticleId><ArticleId IdType="pubmed">28717197</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramasubbu R., Konduru N., Cortese F., Bray S., Gaxiola-Valdez I., Goodyear B. Reduced Intrinsic Connectivity of Amygdala in Adults with Major Depressive Disorder. Front. Psychiatry. 2014;5:1&#x2013;11. doi: 10.3389/fpsyt.2014.00017.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2014.00017</ArticleId><ArticleId IdType="pmc">PMC3928548</ArticleId><ArticleId IdType="pubmed">24600410</ArticleId></ArticleIdList></Reference><Reference><Citation>Krutenkova E.P., Khodanovich M., Bowen J., Gangadharan B., Henson L.K.J., Mayadev A., Repovic P., Qian P.Q., Yarnykh V.L. Demyelination and Iron Accumulation in Subcortical Gray Matter (GM) in Multiple Sclerosis (MS) Ann. Neurol. 2015;78:S65.</Citation></Reference><Reference><Citation>Han H., Ma Q., Li C., Liu R., Zhao L., Wang W., Zhang P., Liu X., Gao G., Liu F., et al. Profiling Serum Cytokines in COVID-19 Patients Reveals IL-6 and IL-10 Are Disease Severity Predictors. Emerg. Microbes Infect. 2020;9:1123&#x2013;1130. doi: 10.1080/22221751.2020.1770129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1770129</ArticleId><ArticleId IdType="pmc">PMC7473317</ArticleId><ArticleId IdType="pubmed">32475230</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunnumakkara A.B., Rana V., Parama D., Banik K., Girisa S., Henamayee S., Thakur K.K., Dutta U., Garodia P., Gupta S.C., et al. COVID-19, Cytokines, Inflammation, and Spices: How Are They Related? Life Sci. 2021;284:119201. doi: 10.1016/j.lfs.2021.119201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2021.119201</ArticleId><ArticleId IdType="pmc">PMC7884924</ArticleId><ArticleId IdType="pubmed">33607159</ArticleId></ArticleIdList></Reference><Reference><Citation>Banks W. Blood-Brain Barrier Transport of Cytokines: A Mechanism for Neuropathology. Curr. Pharm. Des. 2005;11:973&#x2013;984. doi: 10.2174/1381612053381684.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612053381684</ArticleId><ArticleId IdType="pubmed">15777248</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismail I.I., Salama S. Association of CNS Demyelination and COVID-19 Infection: An Updated Systematic Review. Volume 269. Springer; Berlin/Heidelberg, Germany: 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8359762</ArticleId><ArticleId IdType="pubmed">34386902</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J., L&#xfc;tgehetmann M., Hagel C., Sperhake J.P., Schr&#xf6;der A.S., Edler C., Mushumba H., Fitzek A., Allweiss L., Dandri M., et al. Neuropathology of Patients with COVID-19 in Germany: A Post-Mortem Case Series. Lancet Neurol. 2020;19:919&#x2013;929. doi: 10.1016/S1474-4422(20)30308-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30308-2</ArticleId><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J.Y., Zhang W., Roehrl M.W., Roehrl V.B.M.H.W., Roehrl M.H. An Autoantigen Profile from Jurkat T-Lymphoblasts Provides a Molecular Guide for Investigating Autoimmune Sequelae of COVID-19. Aust. J. Chem. 2023;76:508&#x2013;524. doi: 10.1071/CH22268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1071/CH22268</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y., Estes S.K., Ali R.A., Gandhi A.A., Yalavarthi S., Shi H., Sule G., Gockman K., Madison J.A., Zuo M., et al. Prothrombotic Autoantibodies in Serum from Patients Hospitalized with COVID-19. Sci. Transl. Med. 2020;12:eabd3876. doi: 10.1126/scitranslmed.abd3876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abd3876</ArticleId><ArticleId IdType="pmc">PMC7724273</ArticleId><ArticleId IdType="pubmed">33139519</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P., Rosen L.B., Zhang Q., Michailidis E., Hoffmann H.-H., Zhang Y., Dorgham K., Philippot Q., Rosain J., B&#xe9;ziat V., et al. Autoantibodies against Type I IFNs in Patients with Life-Threatening COVID-19. Science. 2020;370:eabd4585. doi: 10.1126/science.abd4585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd4585</ArticleId><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Gazzaruso C., Carlo Stella N., Mariani G., Nai C., Coppola A., Naldani D., Gallotti P. High Prevalence of Antinuclear Antibodies and Lupus Anticoagulant in Patients Hospitalized for SARS-CoV2 Pneumonia. Clin. Rheumatol. 2020;39:2095&#x2013;2097. doi: 10.1007/s10067-020-05180-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-020-05180-7</ArticleId><ArticleId IdType="pmc">PMC7251560</ArticleId><ArticleId IdType="pubmed">32462425</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Zhou L., Bao L., Liu J., Zhu H., Lv Q., Liu R., Chen W., Tong W., Wei Q., et al. SARS-CoV-2 Crosses the Blood&#x2013;Brain Barrier Accompanied with Basement Membrane Disruption without Tight Junctions Alteration. Signal Transduct. Target. Ther. 2021;6:337. doi: 10.1038/s41392-021-00719-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00719-9</ArticleId><ArticleId IdType="pmc">PMC8419672</ArticleId><ArticleId IdType="pubmed">34489403</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy P.G.E. Viral Encephalitis: Causes, Differential Diagnosis, and Management. Neurol. Pract. 2004;75:i10&#x2013;i15. doi: 10.1136/jnnp.2003.034280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2003.034280</ArticleId><ArticleId IdType="pmc">PMC1765650</ArticleId><ArticleId IdType="pubmed">14978145</ArticleId></ArticleIdList></Reference><Reference><Citation>Love S. Demyelinating Diseases. J. Clin. Pathol. 2006;59:1151&#x2013;1159. doi: 10.1136/jcp.2005.031195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jcp.2005.031195</ArticleId><ArticleId IdType="pmc">PMC1860500</ArticleId><ArticleId IdType="pubmed">17071802</ArticleId></ArticleIdList></Reference><Reference><Citation>Brun G., Hak J.F., Coze S., Kaphan E., Carvelli J., Girard N., Stellmann J.P. COVID-19-White Matter and Globus Pallidum Lesions: Demyelination or Small-Vessel Vasculitis? Neurol. Neuroimmunol. neuroinflammation. 2020;7:4&#x2013;6. doi: 10.1212/NXI.0000000000000777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000777</ArticleId><ArticleId IdType="pmc">PMC7286652</ArticleId><ArticleId IdType="pubmed">32444427</ArticleId></ArticleIdList></Reference><Reference><Citation>Conklin J., Frosch M.P., Mukerji S.S., Rapalino O., Maher M.D., Schaefer P.W., Lev M.H., Gonzalez R.G., Das S., Champion S.N., et al. Susceptibility-Weighted Imaging Reveals Cerebral Microvascular Injury in Severe COVID-19. J. Neurol. Sci. 2021;421:117308. doi: 10.1016/j.jns.2021.117308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2021.117308</ArticleId><ArticleId IdType="pmc">PMC7832284</ArticleId><ArticleId IdType="pubmed">33497950</ArticleId></ArticleIdList></Reference><Reference><Citation>Moonis G., Filippi C.G., Kirsch C.F.E., Mohan S., Stein E.G., Hirsch J.A., Mahajan A. The Spectrum of Neuroimaging Findings on CT and MRI in Adults With COVID-19. Am. J. Roentgenol. 2021;217:1&#x2013;16. doi: 10.2214/AJR.20.24839.</Citation><ArticleIdList><ArticleId IdType="doi">10.2214/AJR.20.24839</ArticleId><ArticleId IdType="pubmed">33236647</ArticleId></ArticleIdList></Reference><Reference><Citation>Pantoni L., Garcia J.H., Gutierrez J.A. Cerebral White Matter Is Highly Vulnerable to Ischemia. Stroke. 1996;27:1641&#x2013;1647. doi: 10.1161/01.STR.27.9.1641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.STR.27.9.1641</ArticleId><ArticleId IdType="pubmed">8784142</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y. Remyelination Is Critical for White Matter Stroke Recovery. Eur. J. Biomed. Res. 2015;1:18&#x2013;22. doi: 10.18088/ejbmr.1.4.2015.pp18-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.18088/ejbmr.1.4.2015.pp18-22</ArticleId></ArticleIdList></Reference><Reference><Citation>Marek S., Tervo-Clemmens B., Calabro F.J., Montez D.F., Kay B.P., Hatoum A.S., Donohue M.R., Foran W., Miller R.L., Hendrickson T.J., et al. Reproducible Brain-Wide Association Studies Require Thousands of Individuals. Nature. 2022;603:654&#x2013;660. doi: 10.1038/s41586-022-04492-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04492-9</ArticleId><ArticleId IdType="pmc">PMC8991999</ArticleId><ArticleId IdType="pubmed">35296861</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannouli V. Predictive Factors of Depressive Symptoms of Elderly Patients with Cancer: A Critical Comment. Psychooncology. 2017;26:870. doi: 10.1002/pon.4422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pon.4422</ArticleId><ArticleId IdType="pubmed">28585284</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>